Questdquestd
QU

Quince Therapeutics

Active

Quince Therapeutics Quince Therapeutics (fka Cortexyme) is a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases.

Quince Therapeutics Quince Therapeutics (fka Cortexyme) is a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases. quincetx.com Healthcare Milestones Founded 2012 Partnered 2018 IPO 2019

Tags

BiotechClinical TrialsDiagnosticsDrug DiscoveryHealthcareRare Diseases

Investors

sequoia-capitalvc

sequoia · 2018

Source
Quince Therapeutics — Quince Therapeutics Quince Therapeutics (fka Cortexyme) is a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases. | Questd